A striking 52% rise in oral glucose absorption is seen in #MASLD, spotlighting the gut–liver axis as a potential early driver of disease @MetaLab_Unipi https://t.co/6obsVtBb2r 🔓
A striking 52% rise in oral glucose absorption is seen in #MASLD, spotlighting the gut–liver axis as a potential early driver of disease @MetaLab_Unipi https://t.co/6obsVtBb2r 🔓
The 2nd EASD Diabetes #Technology School 2026 has ended.🎓
Thank you to all participants and to our fantastic faculty, @JuliaMader, @PratikChoudhary, @PieterGillard & @JuliaWare for making Vienna a stimulating experience for the #diabetes community.
Until next time!👏
Warmest wishes from the MetaLab at the University of Pisa 🎉
From our team of researchers, we send our very best wishes for success, inspiration, and new discoveries ahead.
#MetaLab#UniversityOfPisa
Happening now in Düsseldorf! 🚀
Great start of our meeting with Prof. Roden’s opening lecture on precision diabetology, followed by talks on prevention & diabetes heterogeneity. Fantastic energy & networking!🤝
Thanks to the DDZ for hosting, excited for what’s ahead!
#Diabetes
Celebrating 2026 achievements!
Our talented young researchers @SantoniLorenza and @LucaSacchetta94 have successfully completed their residency and are now proud specialists in Internal Medicine.
Salt sensitivity of #bloodpressure: are SGLT2 inhibitors the new heroes?
Find out how #SGLT2i reduce the hypertensive response to high #sodium in type 2 diabetes 🧂🧂🧂
Look up our new paper in Cardiovascular Diabetolgy ➡️ @MetaLab_Unipi@BioMedCentral
https://t.co/FCYYtP9PQ4
🚀 GLP-1 medicines have revolutionized the treatment of type 2 diabetes and obesity.
⚖️ However, there is tremendous heterogeneity in response to treatment and significant unmet need exists.
📊 42.9% of those with type 2 diabetes failed to have clinically meaningful improvement in glycemic control or body weight, according to a real world study of European adults with type 2 diabetes
❗📉 Only 14% achieved meaningful reductions in BOTH a1c and body weight.
https://t.co/X5h3rX2IAh
Our one and only Prof. Domenico Tricò @DomenTrico, our wild card during the last @EASDnews Annual Meeting, member of the @EASDacademy Committee, serving:
-Oral presentations
-Moderations
-Interviews
-Lectures
-And more!
Memories from the last EASD annual meeting: Dr. Simone Gallo on stage, talking about Diabetes complications and how to predict their development.
@EASDnews@Sid_Italia
Congrats to our Dr. Noemi Cimbalo for winning the Early Career Academy Best Abstract Award at 61th @EASDnews!
A huge emotion for all the Meta Lab Team! 🏆 @noemicimb
🎉Thanks to everyone who joined our Social Networking Event at #EASD2025!
🤝The EASD Member Lounge was buzzing with early-career researchers – what an amazing atmosphere!
🏆Congrats to all Best Abstract Awardees – we can’t wait to see your impact in diabetes research!🚀
#diabetes
Lights on Dr. Chiriacò, who presented the results of the patient-level analysis of CANVAS and CREDENCE trials at 61th EASD Annual Meeting in Vienna!
@MartinaChiriac3@EASDnews#EASD2025
Live from Riccione:
Prof Andrea Natali is moderating the session "Reaching the Target in Precision Diabetology: Barriers and Interactions"!
@Sid_Italia
Final day in Pisa🎉Huge thanks to @SantAnnaPisa, @MetaLab_Unipi & @unipi for providing us with a great space, & to everyone who made our 1st meeting a success.
The momentum doesn’t stop here! Our Mentorship Programme is still open until 5 May! Apply now👉 https://t.co/yzDACz8kBH